BioMall
Brand Store/BDB Bioscience/BD PharmingenTM Purified NA/LE Mouse Anti-Mouse CD28
BD PharmingenTM Purified NA/LE Mouse Anti-Mouse CD28
GENERAL CATALOGUE

BD PharmingenTM Purified NA/LE Mouse Anti-Mouse CD28

566883 ·

BDB Bioscience · Cat: 566883

₹350 – ₹550 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 566883
Category: reagents
Brand: BDB Bioscience

Description

Flow cytometric analysis of CD28 expression on mouse splenocytes. BALB/c mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either Purified Mouse IgG1, kappa Isotype Control Cat. No. 556648; dashed line histogram or Purified NA/LE Mouse Anti-Mouse CD28 antibody Cat. No. 566883; solid line histogram at 1 mug/test followed by Biotin Rat Anti-Mouse IgG1 antibody Cat. No. 553441 and then PE Streptavidin Cat. No. 554061 . The fluorescence histogram showing CD28 expression or Ig isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of proliferating mouse splenocytes stimulated with either Anti-CD3 plus Anti-CD28 antibodies or Anti-CD28 antibody alone. C57BL/6 mouse spleen cells were treated with BD Pharm Lyse Lysing Buffer Cat. No. 555899 to lyse erythrocytes. The splenic leucocytes were washed and labeled with BD Horizon CFSE 5 muM; Cat. No. 565082 for 10 minutes at 37C. The cells were washed twice and then cultured with either Purified NA/LE Hamster Anti-Mouse CD3e 10 mug/ml plate-bound; Cat. No. 553057 and Purified NA/LE Mouse Anti-Mouse CD28 1 mug/ml soluble; Cat. No. 566883 antibodies Left Plot or with Purified NA/LE Mouse Anti-Mouse CD28 antibody 1 mug/ml soluble alone Right Plot . After 3 days, the cells were harvested, washed, and stained with BD Horizon BUV395 Rat Anti-Mouse CD4 antibody Cat. No. 563790 . BD Pharmingen DAPI Solution Cat. No. 564907 was added to samples prior to acquisition to exclude non-viable cells. Two-color flow cytometric dot plots showing the correlated expression of CFSE staining versus CD4 levels were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of CD28 expression on mouse splenocytes. BALB/c mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either Purified Mouse IgG1, kappa Isotype Control Cat. No. 556648; dashed line histogram or Purified NA/LE Mouse Anti-Mouse CD28 antibody Cat. No. 566883; solid line histogram at 1 mug/test followed by Biotin Rat Anti-Mouse IgG1 antibody Cat. No. 553441 and then PE Streptavidin Cat. No. 554061 . The fluorescence histogram showing CD28 expression or Ig isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of proliferating mouse splenocytes stimulated with either Anti-CD3 plus Anti-CD28 antibodies or Anti-CD28 antibody alone. C57BL/6 mouse spleen cells were treated with BD Pharm Lyse Lysing Buffer Cat. No. 555899 to lyse erythrocytes. The splenic leucocytes were washed and labeled with BD Horizon CFSE 5 muM; Cat. No. 565082 for 10 minutes at 37C. The cells were washed twice and then cultured with either Purified NA/LE Hamster Anti-Mouse CD3e 10 mug/ml plate-bound; Cat. No. 553057 and Purified NA/LE Mouse Anti-Mouse CD28 1 mug/ml soluble; Cat. No. 566883 antibodies Left Plot or with Purified NA/LE Mouse Anti-Mouse CD28 antibody 1 mug/ml soluble alone Right Plot . After 3 days, the cells were harvested, washed, and stained with BD Horizon BUV395 Rat Anti-Mouse CD4 antibody Cat. No. 563790 . BD Pharmingen DAPI Solution Cat. No. 564907 was added to samples prior to acquisition to exclude non-viable cells. Two-color flow cytometric dot plots showing the correlated expression of CFSE staining versus CD4 levels were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of CD28 expression on mouse splenocytes. BALB/c mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either Purified Mouse IgG1, kappa Isotype Control Cat. No. 556648; dashed line histogram or Purified NA/LE Mouse Anti-Mouse CD28 antibody Cat. No. 566883; solid line histogram at 1 mug/test followed by Biotin Rat Anti-Mouse IgG1 antibody Cat. No. 553441 and then PE Streptavidin Cat. No. 554061 . The fluorescence histogram showing CD28 expression or Ig isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of proliferating mouse splenocytes stimulated with either Anti-CD3 plus Anti-CD28 antibodies or Anti-CD28 antibody alone. C57BL/6 mouse spleen cells were treated with BD Pharm Lyse Lysing Buffer Cat. No. 555899 to lyse erythrocytes. The splenic leucocytes were washed and labeled with BD Horizon CFSE 5 muM; Cat. No. 565082 for 10 minutes at 37C. The cells were washed twice and then cultured with either Purified NA/LE Hamster Anti-Mouse CD3e 10 mug/ml plate-bound; Cat. No. 553057 and Purified NA/LE Mouse Anti-Mouse CD28 1 mug/ml soluble; Cat. No. 566883 antibodies Left Plot or with Purified NA/LE Mouse Anti-Mouse CD28 antibody 1 mug/ml soluble alone Right Plot . After 3 days, the cells were harvested, washed, and stained with BD Horizon BUV395 Rat Anti-Mouse CD4 antibody Cat. No. 563790 . BD Pharmingen DAPI Solution Cat. No. 564907 was added to samples prior to acquisition to exclude non-viable cells. Two-color flow cytometric dot plots showing the correlated expression of CFSE staining versus CD4 levels were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents